Pharmacological and Non-pharmacological Approaches for the Management of Neuropathic Pain in Multiple Sclerosis
Multiple sclerosis is a chronic inflammatory disease that affects the central nervous system
and can cause various types of pain including ongoing extremity pain, Lhermitte's …
and can cause various types of pain including ongoing extremity pain, Lhermitte's …
Managing neuropathic pain in multiple sclerosis: pharmacological interventions
SS Duffy, JG Lees, CJ Perera… - Medicinal …, 2018 - ingentaconnect.com
Background: Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the
central nervous system (CNS). Of the plethora of motor and sensory disturbances …
central nervous system (CNS). Of the plethora of motor and sensory disturbances …
Neuropathic pain in multiple sclerosis–current therapeutic intervention and future treatment perspectives
Chronic pain is defined as any consistent pain lasting more than 12 weeks; chronic pain
afflicts 25% of the world's population. The most common form of chronic pain is chronic …
afflicts 25% of the world's population. The most common form of chronic pain is chronic …
Pharmacotherapeutic options for managing pain in multiple sclerosis
G Di Stefano, G De Stefano, A Di Lionardo, G Cruccu… - CNS drugs, 2020 - Springer
Pain is a major matter for patients with multiple sclerosis; treatment response is frequently
inadequate, with a significant impact on quality of life. The estimated prevalence of pain in …
inadequate, with a significant impact on quality of life. The estimated prevalence of pain in …
Pharmacological management of pain in patients with multiple sclerosis
C Solaro, MM Uccelli - Drugs, 2010 - Springer
Multiple sclerosis (MS) is an inflammatory, demyelinating, autoimmune disease of the CNS.
There are currently a number of disease-modifying medications for MS that modulate or …
There are currently a number of disease-modifying medications for MS that modulate or …
An update on the pharmacological management of pain in patients with multiple sclerosis
CG Chisari, E Sgarlata, S Arena… - Expert opinion on …, 2020 - Taylor & Francis
Introduction The prevalence of pain in Multiple Sclerosis (MS) is estimated to be between 29-
86% depending on various stages of the disease. According to a recent mechanism-based …
86% depending on various stages of the disease. According to a recent mechanism-based …
Pharmacological treatment of pain in multiple sclerosis
C Solaro, P Tanganelli… - Expert Review of …, 2007 - Taylor & Francis
Pain is a common symptom in multiple sclerosis (MS) and was recently estimated to be
experienced by up to 75% of patients. Nociceptive and neuropathic pain in MS may be …
experienced by up to 75% of patients. Nociceptive and neuropathic pain in MS may be …
Advances in the understanding and management of chronic pain in multiple sclerosis: a comprehensive review
I Urits, L Adamian, J Fiocchi, D Hoyt, C Ernst… - Current pain and …, 2019 - Springer
Abstract Purpose of Review Multiple sclerosis (MS) is an autoimmune disorder of the central
nervous system that can lead to severe physical, cognitive, and neurological deficits that …
nervous system that can lead to severe physical, cognitive, and neurological deficits that …
Management of pain in multiple sclerosis: a pharmacological approach
C Solaro, M Messmer Uccelli - Nature Reviews Neurology, 2011 - nature.com
About half of patients with multiple sclerosis (MS) report pain; treatment for pain alone
accounts for nearly 30% of the total use of medications for the management of all MS-related …
accounts for nearly 30% of the total use of medications for the management of all MS-related …
A systematic review of pharmacological pain management in multiple sclerosis
Background Both chronic and acute pain have been cited as the most common symptoms
amongst patients with multiple sclerosis (MS), with recent prevalence estimates as high as …
amongst patients with multiple sclerosis (MS), with recent prevalence estimates as high as …